NM pulmonary presentations
Topic
|
Presenter
|
Dates and Time
|
PG5: ADVANCES IN THE HOME MANAGEMENT OF CHRONIC RESPIRATORY FAILURE
Understanding NIV: Respiratory Assist Device (RAD) Versus Home Mechanical Ventilator
|
5/13/2022
8:05 AM-8:35 AM |
Station 3 - Astral and Vivo 45LS Ventilators + Sip Ventilation
|
5/13/2022
1:30 PM - 1:45 PM |
PG15: DIFFICULT CLINICAL QUESTIONS IN PULMONARY AND CRITICAL CARE INFECTIONS
How Should VAP Be Defined and Treated?
|
5/14/2022
8:30AM - 8:55 AM |
A5: CROSSTALK OF SENESCENT CELLS WITH THE MICROENVIRONMENT: IT TAKES TWO TO TELL A STORY
Chair
|
5/15/2022
9:30 AM - 11:00 AM |
Age-Related Changes in Immune Cell Function
|
5/15/2022
10:00 AM - 10:20 AM |
A10: THE AFTERMATH OF LUNG INFECTION: RECOVERED LUNGS ARE DIFFERENT LUNG
New Macrophage Biology in the Recovered Lung
|
5/15/2022
9:48 AM -10:06 AM |
SA14: INVESTIGATING COPD HEALTH INEQUITIES
Moderator
|
5/15/2022
9:30 AM -11:00 AM |
A44: ICU CURRICULUM AND SYSTEM
Disconnect Between Provider Expectations and Delivered Therapy: Implications for Patients with Artificial Airways
|
5/15/2022
11:15 AM - 1:15 PM |
L15: UPDATE ON AMERICAN LUNG ASSOCIATION AIRWAYS CLINICAL RESEARCH CENTERS NETWORK’S STUDIE
Chair
|
5/16/2022
12:00 PM- 1:00 PM |
ME25: NEUROLOGIC DISASTERS IN THE IC
Faculty
|
5/16/2022
12:15 PM -1:15 PM |
B82: CRITICAL CHALLENGES AND COMPELLING QUESTIONS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEAS
COPD Prevention: Role of Emerging Exposures and Risk Factors on COPD Development
|
5/16/2022
2:18 PM - 2:32 PM |
B107: MOLECULAR MECHANISMS OF SARS-CoV-2, INFLUENZA, AND OTHER LUNG INFECTION
Co-Infections and the Host Response in Non-COVID-19 Pneumonia
|
5/17/2022
2:35 PM- 2:55 PM |
D4: BEDSIDE TO WEBSIDE: ICU TELEMEDICINE MEETING THE DEMANDS OF THE CHANGING TIME
Chair
|
5/18/2022 8:15 AM- 9:45 AM
|
D82: KEEPING THE 'HOME' IN HOME MECHANICAL VENTILATION FOR NEUROMUSCULAR RESPIRATORY FAILURE: TRANSITIONING HOME AND STAYING HOME WITH TELEMEDICIN
Chair
|
5/18/2022
12:45 PM- 2:15 PM |
NORTHWESTERN MEDICINE pulmonary
Northwestern Medicine Pulmonary, Critical Care and Thoracic Surgery is a national leader in research and clinical care of lung diseases and critical illnesses. The team is committed to improving patient outcomes through leading-edge clinical and translational research related to pneumonia, chronic obstructive pulmonary disease, asthma, cystic fibrosis, acute respiratory distress syndrome, pulmonary hypertension, interstitial lung disease, sarcoidosis, quality improvement in critical care, non invasive mechanical ventilation and lung transplantation.
|